Inactive Instrument

Highlights THES ACQU

Equities

RACA

US88339T1034

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Point Biopharma Inc. completed the acquisition of Therapeutics Acquisition Corp. from Therapeutics Acquisition Holdings LLC and other shareholders in a reverse merger transaction.	29/06/21	CI
THERAPEUTICS ACQUISITION CORP. : Other Events (form 8-K)	21/06/21	AQ
Therapeutics Acquisition : Research Alliance Corp. I Announces Effectiveness of Registration Statement for Proposed Business Combination with POINT. Special Meeting Scheduled for June 29, 2021 (Form 8-K)	09/06/21	PU
Therapeutics Acquisition : Research Alliance Corp. I Announces Effectiveness of Registration Statement for Proposed Business Combination with POINT	09/06/21	BU
Therapeutics Acquisition : POINT Biopharma Announces First Patients Dosed in Phase 3 Study of PNT2002 for mCRPC (Form 8-K)	04/06/21	PU
POINT Biopharma Announces First Patients Dosed in Phase 3 Study of PNT2002 for mCRPC	04/06/21	CI
Therapeutics Acquisition : Globally focused radiopharmaceutical company achieves significant milestone to accelerate the operationalization of their 80,000 sq ft radioligand manufacturing facility (Form 8-K)	01/06/21	PU
Therapeutics Acquisition : POINT Biopharma Receives U.S. Nuclear Regulatory Commission Materials License for Indiana Facility	01/06/21	BU
Therapeutics Acquisition Corp. Reports Earnings Results for the First Quarter Ended March 31, 2021	29/04/21	CI
Merck : Completes Pandion Therapeutics Acquisition	01/04/21	MT
Therapeutics Acquisition : POINT Biopharma To Go Public Via SPAC Combination	15/03/21	MT
Point Biopharma Inc. entered into a non-binding letter of intent to acquire Therapeutics Acquisition Corp. from Therapeutics Acquisition Holdings LLC and other shareholders in a reverse merger transaction.	14/03/21	CI
Therapeutics Acquisition Corp. :, Sponsored by RA Capital Management, L.P., Announces Closing of $135.7 Million Initial Public Offering, Including the Full Exercise of the Underwriter’s Option To Purchase Additional Shares	10/07/20	BU
Therapeutics Acquisition Corp. has completed an IPO in the amount of $118 million.	08/07/20	CI
Therapeutics Acquisition Corp. has filed an IPO in the amount of $100 million.	15/06/20	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

The best tools reserved for subscribers to boost the performance of your investments!

Optimize my profits

fermer